Safety and Effectiveness of Coronary Angiography or Intervention through the Distal Radial Access: A Meta-Analysis

Jun Cao1, Huaxiu Cai2, Weibin Liu1

  • 1Department of Cardiology, Ganzhou Municipal Hospital, Ganzhou 341000, China.

Insights

Distal radial access (DRA) for coronary angiography is as effective as traditional transradial access (TRA) regarding success rates and hematoma. DRA significantly reduces radial artery occlusion and spasm, enhancing patient safety.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Vascular Access

Background:

  • Transradial access (TRA) is a common approach for coronary angiography and intervention.
  • Distal radial access (DRA) is an alternative technique with potential benefits.
  • Evaluating the comparative safety and efficacy of DRA versus TRA is crucial for clinical practice.

Purpose of the Study:

  • To conduct a meta-analysis comparing distal radial access (DRA) with transradial access (TRA) for coronary angiography (CAG) or intervention.
  • To assess the effectiveness and safety of DRA based on key clinical endpoints.

Main Methods:

  • Systematic literature search of randomized controlled trials (RCTs) comparing DRA and TRA.
  • Inclusion of studies published between January 1, 2017, and May 4, 2021, from PubMed, Embase, and Cochrane databases.
  • Meta-analysis using a random-effects model to evaluate access success, radial artery occlusion, radial artery spasm, and puncture site hematoma rates.

Main Results:

  • Six RCTs involving 2825 participants met the inclusion criteria.
  • DRA demonstrated a similar access success rate (p=0.1) and lower incidence of puncture site hematoma (p=0.646) compared to TRA.
  • DRA showed significantly lower rates of radial artery occlusion (p < 0.001) and radial artery spasm (p=0.029) than TRA.

Conclusions:

  • Distal radial access (DRA) offers comparable success rates and hematoma incidence to transradial access (TRA).
  • DRA significantly reduces the occurrence of radial artery occlusion and spasm.
  • These findings support DRA as a safe and effective alternative access route for coronary angiography and intervention.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
63
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
52
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
45
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
41
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
758